Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Injection of OnabotulinumtoxinA (BTX-A) into the bladder is a widely used treatment option
for patients with overactive bladder who have failed medical therapy. Urinary tract infection
is the most common side effect of this procedure and therefore antibiotics are given around
the time of injection in order to prevent these events. While antibiotics are commonly given
at the time of injection, the duration of these antibiotic regimens are variable. The
investigators propose a study to investigate different antibiotic protocols and their affect
on the rate of urinary tract infection after injection.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Medical Center
Collaborators:
Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction The Allergan Foundation
Treatments:
abobotulinumtoxinA Anti-Bacterial Agents Antibiotics, Antitubercular Botulinum Toxins, Type A onabotulinumtoxinA Sulfamethoxazole Trimethoprim